CTLA4 and neoplasm: Anti-CTLA-4 primarily targets the lymph node region, facilitating the generation and multiplication of activated T cells, while PD-1 antagonists predominantly function at the tumor periphery, inhibiting tumor progression.-infiltrating tumor PD-L1-expressing tumors and plasma-like dendritic cells from neutralizing cytotoxic T cells (40).